Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joseph C. Siglin is active.

Publication


Featured researches published by Joseph C. Siglin.


Cancer Letters | 1996

Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin

Michael A. Hawk; Kimberley T. Cesen; Joseph C. Siglin; Gary D. Stoner; Randall J. Ruch

The HMG-CoA reductase inhibitor, lovastatin (LOV), has been reported to inhibit Ras farnesylation and the growth of Ras-transformed cells. Mouse lung tumors and human lung adenocarcinomas often have activating mutations in K-ras alleles. In the present study, we determined whether LOV inhibited the growth in vitro of mouse (C10, E9, LM1, LM2, and 82-132) and human (NCl-H125, H292, H441, H460, and H661) nor-transformed and neoplastically transformed lung epithelial cells and whether growth inhibition was related to cell transformation or K-ras activation. LOV inhibited the growth of mouse and human lung cells, but cell sensitivities were unrelated to neoplastic transformation or K-ras mutation. In addition, we evaluated whether LOV could inhibit the formation of lung adenomas induced by the tobacco-specific nitrosamine, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mice. LOV was administered in the diet at 0, 40, 160, or 400 ppm ad libitum to male strain A/J mice beginning 1 week after lung tumor induction with NNK (10 mumol/mouse). Mice were euthanized 6 months later. Enumeration of lung tumors revealed that LOV did not affect tumor incidence or size, but significantly reduced tumor multiplicity in a dose-related manner. These data suggest that LOV can suppress the formation of NNK-induced lung tumors, possibly at an early promotional stage. This suppression does not appear to be related to either the presence of mutated K-ras or to changes in K-ras expression.


Toxicological Sciences | 1990

Variability of a mouse ear swelling test (MEST) in predicting weak and moderate contact sensitization

Brendan J. Dunn; George M. Rusch; Joseph C. Siglin; Donna L. Blaszcak

An investigation was conducted at two independent laboratories for the purpose of evaluating the ability of a mouse ear swelling test (MEST), previously developed and validated by S.C. Gad. B.J. Dunn, D. W. Dobbs, C. Reilly, and R.D. Walsh (1986, Toxicol. Appl. Pharmacol. 84, 93-114), to predict contact sensitization induced by weak to moderate contact sensitizers. Twenty-six coded chemicals, 23 with weak to strong potential to induce sensitization in animals and/or humans and 3 negative controls, were investigated. Each laboratory tested 18 materials: 10 chemicals were common to both labs and 16 chemicals were divided so that 8 were unique to each of the two labs. The methods and chemicals utilized were the same as those used and reported by Gad et al. (1986) and, therefore, data generated from this investigation were compared to results from their research. Contrary to results reported by Gad and co-workers, findings from the present study suggest that this MEST is a useful model for identifying strong contact sensitizers, but is not reliable for detecting weak to moderate allergens.


Carcinogenesis | 2001

Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries

Peter S. Carlton; Laura A. Kresty; Joseph C. Siglin; Mark A. Morse; Jerry Lu; Charlotte Morgan; Gary D. Stoner


Toxicological Sciences | 1999

Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer.

Gary D. Stoner; Laura A. Kresty; Peter S. Carlton; Joseph C. Siglin; Mark A. Morse


Toxicological Sciences | 2000

A 90-Day Drinking Water Toxicity Study in Rats of the Environmental Contaminant Ammonium Perchlorate

Joseph C. Siglin; David R. Mattie; Darol E. Dodd; Paul K. Hildebrandt; William H. Baker


Carcinogenesis | 1995

Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats

Joseph C. Siglin; David H. Brach; Gary D. Stoner


Carcinogenesis | 1995

Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate

Gary D. Stoner; Joseph C. Siglin; Mark A. Morse; Dhimant Desai; Shantu Amin; Laura A. Kresty; Amy L. Toburen; Erika M. Heffner; David J. Francis


Carcinogenesis | 1995

Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats

Joseph C. Siglin; Leena Khare; Gary D. Stoner


Carcinogenesis | 1996

O6 -Methyguanine levels and histopathological changes in the rat esophagus and liver following single and repeated administration of N -nitrosomethylbenzylamin

Joseph C. Siglin; Mark A. Morse; Herman A.J. Schut; Robert G. Geil; Philip B. Conran; Gary D. Stoner


Toxicological Sciences | 1996

Subchronic, Developmental, and Genetic Toxicology Studies with the Ethane Sulfonate Metabolite of Alachlor

William F. Heydens; Joseph C. Siglin; Joseph F. Holson; Sheila D. Stegeman

Collaboration


Dive into the Joseph C. Siglin's collaboration.

Top Co-Authors

Avatar

Gary D. Stoner

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura A. Kresty

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aaron M. Sargeant

Charles River Laboratories

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Binod Jacob

Charles River Laboratories

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge